Single-use scopes take center stage at Ambu as core business areas recede

Ambu's traditional core business, Anaesthesia and Patient Monitoring & Diagnostics (PMD), is now playing a supporting role to single-use endoscopes, which account for most of the medtech company's sales growth. Ambu will still ensure that its former core business remains competitive, but development funding is now going in a different direction.

Photo: Ambu / PR

Medtech company Ambu's year has been somewhat of a mixed bag.

While its business area within single-use endoscopes, called Visualization, has stormed ahead, the company's traditional core focus on Anaesthesia and Patient Monitoring & Diagnostics (PMD) has not had it as easy.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs